DiamondTemp™ Ablation System for the Treatment of Paroxysmal Atrial Fibrillation

Completed · Not applicable

Conditions studied: Paroxysmal Atrial Fibrillation, Atrial Fibrillation

In brief

The purpose of the DIAMOND-AF study is to establish the safety and effectiveness of the DiamondTemp System for the treatment of drug refractory, recurrent, symptomatic paroxysmal atrial fibrillation in patients.

Key facts

Study ID
NCT03334630
Run by
Medtronic Cardiac Ablation Solutions
People needed
482
Starts
2017-11-06
Expected to finish
2019-12-03
Last updated by the study team
2025-02-13

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.